News from q biomed inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 01, 2019, 10:23 ET Q BioMed to Present at 2019 BIO CEO & Investor Conference

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today the Company's CEO Denis Corin will deliver a corporate...


Aug 20, 2018, 09:29 ET Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain

Q BioMed Inc. (OTCQB: QBIO) (OtherOTC: QBIO), a commercial stage biotechnology acceleration development company, and BioNucleonics, licensor of...


Dec 21, 2017, 07:30 ET Q BioMed Provides Year End Update

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to provide this year end update to its shareholders. The Company ends...


Apr 25, 2017, 07:00 ET Q Biomed Announces Licensing Agreement for Development of Drug to Treat Rare Pediatric Disorder

Q BioMed Inc. (OTCQB: QBIO) and ASDERA LLC today announce a licensing agreement that provides Q Biomed with the worldwide exclusive rights to...


Feb 07, 2017, 07:00 ET Q Biomed Joins with Oklahoma Medical Research Foundation and Rajiv Gandhi Centre for Biotechnology to Develop Liver Cancer Chemotherapeutic

Q BioMed, Inc. (OTCQB: QBIO) has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for...


Feb 02, 2017, 07:00 ET Q BioMed Inc. Announces Mannin Research Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that Mannin Research, its research partner for the...


Jan 05, 2017, 09:09 ET Q BioMed Inc. to Present at Biotech Showcase 2017 in San Francisco Jan 9 - 11th

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration and development company will present at the 9th Annual Biotech Showcase™ 2017 being held...


Nov 30, 2016, 08:30 ET Q BioMed Inc. Announces Entry Into Definitive Funding Agreement for up to $4,000,000

Q BioMed Inc. (OTCQB: QBIO), is pleased to announce that it has entered into a definitive agreement with Yorkville Advisors Global ("Yorkville") for...


Oct 19, 2016, 03:04 ET Q BioMed Inc. Technology Partner Mannin Research Inc. to Participate in a Webcast on Innovating for Ophthalmic Diseases

Q BioMed Inc. (OTCQB: QBIO), technology partner Mannin Research Inc. will present in a webcast on Innovating for Ophthalmic Diseases on October 20th...


Oct 18, 2016, 09:29 ET Q BioMed Drug Development Partner to Attend EANM 2016 in Barcelona, Spain October 15-19 2016

Q BioMed Inc. (OTCQB: QBIO), Strontium Chloride 89 (SR89) drug development partner will attend the European Association of Nuclear Medicine (EANM)...


Oct 13, 2016, 09:03 ET Q BioMed Partner Mannin Research Executives Attending OIS@AAO 2016 & AAO

Q BioMed Inc. (OTCQB: QBIO), technology partner Mannin Research Inc will participate at the Ophthalmology Innovation Summit and the American Academy...


Oct 07, 2016, 09:18 ET Q Biomed Comments on its Glaucoma Drug and Industry News in the Ophthalmology Space

Media Alert: CEO Interviewed on Wall St Analyst Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company with a glaucoma drug in development ...


Sep 07, 2016, 04:15 ET Q BioMed Closes Licensing Agreement for FDA Approved Drug

Cancer palliation drug expected to start generating revenue in less than 12 months Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company...


Sep 01, 2016, 08:30 ET Q BioMed Provides Update On Corporate Developments

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to report on its asset acquisition and an update on corporate...


Jul 14, 2016, 08:30 ET Q BioMed Inc. Advisor and Mannin Research Inc CSO Dr Susan Quaggin Elequently Discusses Glaucoma and Man-01 with Eye on Vision Radio

Q BioMed Inc. (OTCQB: QBIO), partner Mannin Research Inc. CSO Dr. Susan Quaggin discusses glaucoma, treatment options, and her novel findings on the...


Jun 01, 2016, 08:30 ET Q BioMed Inc. Reports on Current and New Potential Assets

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to report on new potential asset license/acquisition and an update on...


May 26, 2016, 08:30 ET Q BioMed Inc. to Present at the Fifth Annual Marcum Microcap Conference in New York

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that it will be a featured presenter at the 5th Annual Marcum...


May 02, 2016, 09:15 ET Mannin Research to Participate at ARVO 2016 Meeting

Q BioMed Inc. (QBIO), a biotechnology acceleration company announces that its technology partner Mannin Research Inc. will be attending the...


Apr 28, 2016, 09:51 ET Media Alert - Q BioMed Inc CEO Pens Management Piece Featured in Life Science Leader

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company reports the Company's CEO was featured in an article he wrote on venture capital...


Apr 26, 2016, 08:30 ET Q BioMed Inc. to Present at the Global Chinese Financial Forum on April 30, 2016

Toronto, ON Conference Expects to Attract Over 200 Participants. Q BioMed Inc. (OTCQB: QBIO) a biotechnology acceleration company, today announced...


Apr 12, 2016, 11:15 ET Mannin Research to Present Glaucoma Therapeutics Treatment at MedCity INVEST Chicago April 12-13 2016

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to announce that its license technology partner, Mannin Research, will...


Apr 05, 2016, 09:11 ET Q BioMed Inc Featured in April Issue of PharmaVOICE Magazine

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company reports the Company's CEO was featured in an interview in the April issue of...


Mar 17, 2016, 08:00 ET Q BioMed Inc. Congratulates Mannin Research on Selection to the Chicago-Canada Mentorship Program (C2MP) and Inaugural Meeting

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to congratulate Mannin Research on its selection to the C2MP program and ...


Feb 29, 2016, 09:45 ET Q BioMed Inc. CEO Provides Corporate Overview in an Interview With Scrip Intelligence

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to share the recently published video interview from the Biotech...


Feb 04, 2016, 08:00 ET Q BioMed Inc. Provides a Corporate Update

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to provide the following update on recent corporate developments. Over...